Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Pulmonary Hypertension and Sickle Cell Disease With Sildenafil Therapy

NCT00492531 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.

NCT NCT00492531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00492531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Pulmonary Hypertension and Sickle Cell Disease With Sildenafil Therapy
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Phase
Phase 2
Overall status
Terminated
Start date
June 30, 2007
Completion date
October 31, 2009
Enrollment
74 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary hypertension, sickle cell disease